tiprankstipranks
Mosaic Co (MOS)
NYSE:MOS
Want to see MOS full AI Analyst Report?

Mosaic Co (MOS) AI Stock Analysis

2,117 Followers

Top Page

MOS

Mosaic Co

(NYSE:MOS)

Select Model
Select Model
Select Model
Neutral 51 (OpenAI - 5.2)
Rating:51Neutral
Price Target:
$23.50
▲(5.38% Upside)
Action:Reiterated
Date:08/12/26
The score is held back primarily by weakened financial performance—very thin TTM margins and negative free cash flow—despite a stable balance sheet. Technicals are moderately constructive (improving momentum above key short/intermediate averages), but valuation is challenging given the very high P/E. The latest earnings call adds a mixed outlook: cost/capex discipline and strong volumes offset by raw-material volatility, curtailments, and limited visibility.
Positive Factors
Strong phosphate sales volumes
Sustained top-line volume demonstrates durable commercial reach and inventory conversion capability. Consistently high phosphate shipments lower unit fixed costs, support channel relationships, and provide a base for recovery in margins when input markets normalize, strengthening long-term earnings resilience.
Negative Factors
Deeply negative free cash flow
Sustained negative free cash flow constrains the firm's ability to invest, pay down debt, or return capital without external financing. Over several quarters this limits strategic flexibility, forces refinancing reliance, and raises execution risk for capex or growth initiatives while the fertilizer cycle remains depressed.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong phosphate sales volumes
Sustained top-line volume demonstrates durable commercial reach and inventory conversion capability. Consistently high phosphate shipments lower unit fixed costs, support channel relationships, and provide a base for recovery in margins when input markets normalize, strengthening long-term earnings resilience.
Read all positive factors

Mosaic Co Key Performance Indicators (KPIs)

Any
Any
Adjusted EBITDA by Segment
Adjusted EBITDA by Segment
Provides a breakdown of earnings before interest, taxes, depreciation, and amortization for each business segment, highlighting profitability and operational efficiency across different areas of the company.
Chart InsightsPotash is the clear earnings backbone—more resilient and rebounding through 2025—while Phosphates’ EBITDA has eroded despite management citing the strongest quarterly sales in five years, signaling severe margin compression from soaring sulfur/ammonia costs, curtailments and one‑off idling charges (largely non‑cash). Mosaic Fertilizantes is the most volatile, reflecting Brazil demand and SSP idling. Management’s capex cuts, workforce actions and the planned working‑capital release are defensive moves to protect cash until input‑costs and supply normalize.
Data provided by:The Fly

Mosaic Co (MOS) vs. SPDR S&P 500 ETF (SPY)

Mosaic Co Business Overview & Revenue Model

Company Description
Operating on a global scale via its various subsidiaries, The Mosaic Company specializes in the creation and distribution of concentrated phosphate and potash crop nutrients. Its business is structured into three distinct segments: Phosphates, Pot...
How the Company Makes Money
Mosaic makes money primarily by selling crop nutrient products, with revenue largely driven by (1) sales volumes and (2) realized market prices for fertilizers and related products. Key revenue streams - Phosphates segment: Mosaic generates reven...

Mosaic Co Earnings Call Summary

Earnings Call Date:May 11, 2026
(Q2-2026)
|
% Change Since: |
Next Earnings Date:Nov 10, 2026
Earnings Call Sentiment Neutral
Mixed. The call details significant near-term challenges driven primarily by external sulfur supply disruptions and resulting phosphate curtailments, under-application of phosphate (driving agronomic risk) and some near-term cash pressure (approx. $500M expected shortfall). Offsetting these negatives are multiple company actions and strengths: secured sulfur contracts materially below spot for Q3, strong balance sheet and liquidity actions (term loan, refinancings, untapped revolver), meaningful SG&A reductions (-20% YoY), potash stability and growth projects (Esterhazy HydroFloat), resilient Brazil distribution and co-product margins, fast-growing Mosaic Biosciences, lower CapEx guidance ($1.2B) and an expected working capital release (forecast $300–500M) supporting sequential free cash flow improvement in Q3 and Q4. Overall the transcript portrays a company taking decisive defensive actions to manage a severe but (management believes) temporary market disruption, leading to a balanced view of risk and mitigation.
Positive Updates
Q2 Production and Sales
Produced and sold 1.4 million tonnes of phosphate in Q2 despite market turmoil, demonstrating operational flexibility and strong global customer relationships.
Negative Updates
Severe Sulfur Supply Disruption
Ongoing Strait of Hormuz closure and Kazakhstan blockade materially disrupted global sulfur flows, pushing spot sulfur prices to unsustainably high levels and forcing production curtailments; management estimates global phosphate production could fall short of prior year by up to 30 million tonnes if disruptions persist.
Read all updates
Q2-2026 Updates
Negative
Q2 Production and Sales
Produced and sold 1.4 million tonnes of phosphate in Q2 despite market turmoil, demonstrating operational flexibility and strong global customer relationships.
Read all positive updates
Company Guidance
Mosaic guided third-quarter realized raw‑material costs of about $700–710/ton for sulfur and $610–620/tonne for ammonia (Q2 averages were $522/ton sulfur and $621/tonne ammonia), DAP FOB pricing of $820–840/tonne and implied stripping margins “well above” historical averages; phosphate sales guidance for Q3 was 1.1–1.4 million tonnes (Q2 produced/sold 1.4M t) and Q2 realized stripping margin was $422/tonne. They cut full‑year CapEx to $1.2B (from $1.25B/$1.5B prior) with roughly $300M expected in Q3 and a drop in Q4, reduced SG&A ~20% YoY with further declines forecast, and expect sequential free‑cash‑flow improvement in Q3 and Q4. Mosaic reiterated a $300–500M working‑capital release this year (≈$100–200M in Q3, majority in Q4), Q2 Fertilizantes EBITDA ≈$60M, Q2 MOP costs $84/ton (lower in H2), Biosciences on track to double revenues with ~ $30M Brazil sales in Q3 (~40% margin, ≈$12M contribution), Q2 idle/turnaround charges ≈$60M with Q3 incremental idle/turnaround of roughly $10–20M, and strengthened liquidity via a $1.0B term loan, $500M CP refinanced in June (remainder in July) and an untapped $2.5B revolver.

Mosaic Co Financial Statement Overview

Summary
Overall fundamentals are pressured by the downcycle: TTM profitability is very weak (net margin ~0.4% vs much higher in prior years) and free cash flow is deeply negative (~-$947M). The balance sheet is comparatively steady with manageable leverage and solid equity, but low ROE reflects the earnings slump and cash generation remains the key constraint.
Income Statement
42
Neutral
Balance Sheet
66
Positive
Cash Flow
34
Negative
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue11.88B12.05B11.12B13.70B19.13B12.36B
Gross Profit1.37B1.82B1.51B2.21B5.76B3.20B
EBITDA1.71B2.61B1.57B2.48B5.75B3.23B
Net Income43.20M540.70M174.90M1.16B3.58B1.63B
Balance Sheet
Total Assets24.64B24.48B22.92B23.03B23.39B22.04B
Cash, Cash Equivalents and Short-Term Investments294.00M276.60M272.80M348.80M735.40M769.50M
Total Debt5.86B5.28B4.45B3.99B3.81B4.41B
Total Liabilities13.01B12.25B11.31B10.60B11.19B11.29B
Stockholders Equity11.46B12.08B11.48B12.29B12.05B10.60B
Cash Flow
Free Cash Flow-947.10M-534.60M47.40M1.00B2.69B898.40M
Operating Cash Flow444.00M824.80M1.30B2.41B3.94B2.19B
Investing Cash Flow-1.32B-1.31B-1.26B-1.32B-1.26B-1.32B
Financing Cash Flow875.70M452.00M-131.90M-1.48B-2.68B-682.10M

Mosaic Co Technical Analysis

Technical Analysis Sentiment
Negative
Last Price22.30
Price Trends
50DMA
22.17
Positive
100DMA
22.91
Negative
200DMA
24.48
Negative
Market Momentum
MACD
0.26
Negative
RSI
50.22
Neutral
STOCH
64.41
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MOS, the sentiment is Negative. The current price of 22.3 is below the 20-day moving average (MA) of 22.65, above the 50-day MA of 22.17, and below the 200-day MA of 24.48, indicating a neutral trend. The MACD of 0.26 indicates Negative momentum. The RSI at 50.22 is Neutral, neither overbought nor oversold. The STOCH value of 64.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MOS.

Mosaic Co Risk Analysis

Mosaic Co disclosed 45 risk factors in its most recent earnings report. Mosaic Co reported the most risks in the "Production" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Mosaic Co Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
$18.38B8.7135.17%1.60%20.04%76.29%
71
Outperform
$507.99M18.465.27%4.20%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
57
Neutral
$6.89B22.215.02%3.61%10.92%-16.91%
53
Neutral
$3.63B49.62-21.87%3.81%-1.95%44.91%
51
Neutral
$7.46B117.400.36%3.95%8.84%-167.87%
45
Neutral
$1.31B-0.47-118.57%7.26%-21.31%-2884.91%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MOS
Mosaic Co
22.60
-8.52
-27.38%
CF
Cf Industries Holdings
120.01
35.41
41.85%
FMC
FMC
10.24
-26.01
-71.75%
IPI
Intrepid Potash
36.44
7.43
25.61%
SMG
Scotts Miracle-Gro Company
62.17
1.18
1.94%
ICL
Icl
5.47
-0.42
-7.19%

Mosaic Co Corporate Events

Business Operations and StrategyPrivate Placements and Financing
Mosaic Launches Large Debt Tender Offers for Refinancing
Positive
Aug 10, 2026
On August 10, 2026, Mosaic launched a series of cash tender offers to purchase up to $1.4 billion of its outstanding debt securities, targeting four tranches of senior notes and debentures maturing between 2027 and 2029, with a $150 million cap sp...
Business Operations and StrategyPrivate Placements and Financing
Mosaic Establishes $1 Billion Delayed Draw Term Loan
Positive
Jun 15, 2026
On June 10, 2026, The Mosaic Company entered into a new credit agreement establishing a committed delayed draw term loan facility totaling up to $1 billion, split evenly between a 364-day $500 million tranche and a three-year $500 million tranche....
Executive/Board ChangesShareholder Meetings
Mosaic Shareholders Back Directors, Executive Pay and Auditor
Positive
May 29, 2026
At its 2026 Annual Meeting of Stockholders, Mosaic shareholders elected twelve directors, including CEO Bruce M. Bodine and several incumbent and independent board members, each to a one-year term expiring at the 2027 annual meeting. The vote tall...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 12, 2026